Summary: There is no authorised UK reconstitution ratio for retatrutide, as it remains an unlicensed investigational compound with no approved MHRA guidance, SmPC, or NHS prescribing pathway
The peptide has been found to speed up the process of healing wounds in the tissues, increasing the rate of growth in new blood vessels and helping to repair the gastrointestinal tract while also protecting other internal organs, such as the liver and brain
Injection site reactions possible with any injectable
DISCUSSION BPC 157 was suggested to be a link between inflammatory bowel disease and multiple sclerosis, that could be also used in practice per-orally (as an anti-ulcer peptide, stable in human gastric juice) (5-7, 9), and thereby, being equally effective against the models of both of those diseases
These belong to a class of drugs called incretin mimetics , which either mimic or enhance the effects of gut hormones that regulate appetite and metabolism